肿瘤学前沿(Frontiers In Oncology)是一本由Frontiers Media S.A.出版的一本Biochemistry, Genetics and Molecular Biology-Cancer Research学术刊物,主要报道Biochemistry, Genetics and Molecular Biology-Cancer Research相关领域研究成果与实践。本刊已入选来源期刊,该刊创刊于2011年,出版周期1 issue/year。2021-2022年最...
To make radiogenomic biomarkers reliable in oncology, standardization of assay criteria, image capture, segmentation, trial design, and analytical methods is imperative. Along with this, a focus on creating an extensive imaging database inclusive of genomic profiles, demographics, treatment details, and...
Evidence of surgical interventions go back to prehistoric times. Since then, the field of surgery has developed into a complex array of specialties and procedures, particularly with the advent of microsurgery, lasers and minimally invasive techniques. The advanced skills now required from surgeons has ...
pediatrics.editorial.office@frontiersin.org pediatrics@frontiersin.org 5、官网电话:+41(0)21 510 17 40 6、期刊刊期:不定期出版。 2021年7月1日星期四 投稿须知【官网信息】 Scope & Mission Frontiers in Pediatrics (Impact Factor 2.634) publishes rigorously peer-reviewed research broadly across the field...
(unpaid); consultant and speaker honorarium, Boston Scientific US, 2019; institutional principal investigator for clinical trials sponsored by Celgene, Novocure, Intima Biosciences, and the National Cancer Institute; and University of Minnesota membership in the Caris Life Sciences Precision Oncology ...
(American Society of Clinical Oncology) meeting, BeiGene reported the latest results from the Phase II ROSEWOOD study, evaluating the combination of Zanubrutinib and obinutuzumab in heavily pretreated R/R FL patients. The ROSEWOOD study is a randomized, open-label Phase II clinical trial aimed ...
In the realms of future: new frontiers of ‘technooncology’ as a platform for global improvement in the outcomes of childhood cancer. Expert Rev Hematol 2015; 8(1): 1–4 Article CAS PubMed Google Scholar Banday AH, Jeelani S, Hruby VJ. Cancer vaccine adjuvants—recent clinical progress...
Submission received: 14 June 2024/Revised: 19 July 2024/Accepted: 23 July 2024/Published: 30 July 2024 (This article belongs to the SectionOncology) Downloadkeyboard_arrow_down Versions Notes Abstract Despite the introduction of targeted vaccines and screening protocols, locally advanced cervical cancer...
Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: From melanoma to tissue-agnostic therapy. ESMO Open 2023, 8, 100788. [Google Scholar] [CrossRef] [PubMed] Robert, C.; Thomas, L.; Bondarenko, I.; O’Day, S.; Weber, J.; Garbe, C.; Lebbe, C.; Baurain, ...
Fine B M, Amler L (2009). Predictive biomarkers in the development of oncology drugs: a therapeutic industry perspective. Clin Pharmacol Ther, 85(5): 535–538 ArticlePubMedCASGoogle Scholar Fletcher R H (1986). Carcinoembryonic antigen. Ann Intern Med, 104(1): 66–73 ...